The U.S. FDA's accelerated drug approval process requires greater transparency, states the Institute for Clinical and ...

Lawmakers are clearing the way for use of the psychedelic mushroom compound psilocybin as a potential medical treatment, once ...

WFMY News 2's Kevin Kennedy spoke to a doctor who was part of a clinical trial and legislators about what they're doing to help speed up the process.

Eli Lilly's new daily pill GLP-1 moved through the FDA approval process faster after the FDA's new review and approval process.

Good afternoon, and welcome to the Travere Therapeutics Business Update Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice ...

Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s ...

U.S. health officials have approved a new weight-loss pill from Eli Lilly. The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a ...

Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children ...

Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.

After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...

The FDA meeting announcement​ follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on ...

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients~15,000 children are living with DMD ...